Dr Reddys Laboratories Ltd β APPOINTMENT OF SENIOR MANAGEMENT PERSONNEL
Appointment of new Head API and Services effective November 13, 2026:
- Mr. Akhil Ravi appointed as Head API and Services and Senior Management Personnel
- Mr. Akhil Ravi inducted as a Member of the Management Council
- He will continue to lead operations of Aurigene Pharmaceutical Services Ltd (wholly owned subsidiary)
- Mr. Akhil Ravi brings nearly 19 years of experience in strategy and commercial leadership
- He currently serves as CEO of Aurigene Pharmaceutical Services Ltd
Appointment of new Head API and Services effective November 13, 2026:
- Mr. Akhil Ravi appointed as Head API and Services and Senior Management Personnel
- Mr. Akhil Ravi inducted as a Member of the Management Council
- He will continue to lead operations of Aurigene Pharmaceutical Services Ltd (wholly owned subsidiary)
- Mr. Akhil Ravi brings nearly 19 years of experience in strategy and commercial leadership
- He currently serves as CEO of Aurigene Pharmaceutical Services Ltd
GEOJIT FINANCIAL SERVICES Q2 FY27 (CONS.)
Net Profit: βΉ16.28 Cr β30.62% YoY | β17.87% QoQ
Revenue: βΉ165.82 Cr β2.56% YoY | β3.38% QoQ
EBITDA: βΉ30.34 Cr β1.57% YoY | β4.41% QoQ
EBITDA Margin: 18.30% vs 19.06% YoY | 19.79% QoQ
Net Profit: βΉ16.28 Cr β30.62% YoY | β17.87% QoQ
Revenue: βΉ165.82 Cr β2.56% YoY | β3.38% QoQ
EBITDA: βΉ30.34 Cr β1.57% YoY | β4.41% QoQ
EBITDA Margin: 18.30% vs 19.06% YoY | 19.79% QoQ
RAMCO SYSTEMS Q2 FY27
Net Profit: βΉ0.5 Cr β96% YoY | β20% QoQ
Revenue: βΉ182 Cr β4% YoY | β5% QoQ
EBITDA: βΉ26 Cr β34% YoY | β1% QoQ
EBITDA Margin: 14.2% vs 22.4% YoY | 14.7% QoQ
Net Profit: βΉ0.5 Cr β96% YoY | β20% QoQ
Revenue: βΉ182 Cr β4% YoY | β5% QoQ
EBITDA: βΉ26 Cr β34% YoY | β1% QoQ
EBITDA Margin: 14.2% vs 22.4% YoY | 14.7% QoQ
SHAKTI PUMPS Q2 FY27
Net Profit: βΉ39 Cr β58% YoY | β25% QoQ
Revenue: βΉ746 Cr β12% YoY | β13% QoQ
EBITDA: βΉ64 Cr β53% YoY | β23% QoQ
EBITDA Margin: 8.6% vs 20.4% YoY | 9.6% QoQ
Net Profit: βΉ39 Cr β58% YoY | β25% QoQ
Revenue: βΉ746 Cr β12% YoY | β13% QoQ
EBITDA: βΉ64 Cr β53% YoY | β23% QoQ
EBITDA Margin: 8.6% vs 20.4% YoY | 9.6% QoQ
RUNWAL ENTERPRISES Q1 FY27 (CONS.)
Net Profit: βΉ49.76 Cr β65.21% YoY | βΉ62.02 Cr loss QoQ
Revenue: βΉ338.16 Cr β24.21% YoY | β60.29% QoQ
EBITDA: βΉ66.43 Cr β57.82% YoY | βΉ39.74 Cr loss QoQ
EBITDA Margin: 19.65% vs 35.30% YoY | -18.84% QoQ
Net Profit: βΉ49.76 Cr β65.21% YoY | βΉ62.02 Cr loss QoQ
Revenue: βΉ338.16 Cr β24.21% YoY | β60.29% QoQ
EBITDA: βΉ66.43 Cr β57.82% YoY | βΉ39.74 Cr loss QoQ
EBITDA Margin: 19.65% vs 35.30% YoY | -18.84% QoQ
β€1
SHIVA CEMENT Q2 FY27
Net Loss: βΉ22.85 Cr vs βΉ32.73 Cr loss YoY | βΉ21.35 Cr loss QoQ
Revenue: βΉ112.70 Cr β37.25% YoY | β25.61% QoQ
EBITDA: βΉ17.31 Cr β331.45% YoY | β7.19% QoQ
EBITDA Margin: 15.36% vs 4.89% YoY | 12.31% QoQ
Net Loss: βΉ22.85 Cr vs βΉ32.73 Cr loss YoY | βΉ21.35 Cr loss QoQ
Revenue: βΉ112.70 Cr β37.25% YoY | β25.61% QoQ
EBITDA: βΉ17.31 Cr β331.45% YoY | β7.19% QoQ
EBITDA Margin: 15.36% vs 4.89% YoY | 12.31% QoQ
SBI FUNDS MANAGEMENT Q2 FY27 (CONS.)
Net Profit: βΉ7,012.44 Cr β5.99% YoY | β20.34% QoQ
Revenue: βΉ11,926.72 Cr β8.91% YoY | β3.47% QoQ
EBITDA: βΉ9,126.91 Cr β5.41% YoY | β1.11% QoQ
EBITDA Margin: 76.52% vs 79.07% YoY | 80.07% QoQ
Net Profit: βΉ7,012.44 Cr β5.99% YoY | β20.34% QoQ
Revenue: βΉ11,926.72 Cr β8.91% YoY | β3.47% QoQ
EBITDA: βΉ9,126.91 Cr β5.41% YoY | β1.11% QoQ
EBITDA Margin: 76.52% vs 79.07% YoY | 80.07% QoQ
TRUALT BIOENERGY Q2 FY27 (CONS.)
Net Profit: βΉ34.99 Cr vs βΉ37.94 Cr loss YoY | β40.96% QoQ
Revenue: βΉ811.10 Cr β606.17% YoY | β29.39% QoQ
EBITDA: βΉ101.16 Cr vs βΉ4.55 Cr loss YoY | β23.80% QoQ
EBITDA Margin: 12.47% vs -3.96% YoY | 21.18% QoQ
Net Profit: βΉ34.99 Cr vs βΉ37.94 Cr loss YoY | β40.96% QoQ
Revenue: βΉ811.10 Cr β606.17% YoY | β29.39% QoQ
EBITDA: βΉ101.16 Cr vs βΉ4.55 Cr loss YoY | β23.80% QoQ
EBITDA Margin: 12.47% vs -3.96% YoY | 21.18% QoQ
SUPREME PETROCHEM Q2 FY27
Net Profit: βΉ97 Cr β100% YoY | β59% QoQ
Revenue: βΉ1,984 Cr β77% YoY | β16% QoQ
EBITDA: βΉ152 Cr β93% YoY | β54% QoQ
EBITDA Margin: 7.7% vs 7.0% YoY | 19.4% QoQ
Net Profit: βΉ97 Cr β100% YoY | β59% QoQ
Revenue: βΉ1,984 Cr β77% YoY | β16% QoQ
EBITDA: βΉ152 Cr β93% YoY | β54% QoQ
EBITDA Margin: 7.7% vs 7.0% YoY | 19.4% QoQ
UTI AMC Q2 FY27
Net Profit: βΉ132 Cr Flat YoY | β55% QoQ
Revenue: βΉ415 Cr β1% YoY | β29% QoQ
EBITDA: βΉ191 Cr β8% YoY | β50% QoQ
EBITDA Margin: 46.2% vs 42.3% YoY | 65.6% QoQ
Net Profit: βΉ132 Cr Flat YoY | β55% QoQ
Revenue: βΉ415 Cr β1% YoY | β29% QoQ
EBITDA: βΉ191 Cr β8% YoY | β50% QoQ
EBITDA Margin: 46.2% vs 42.3% YoY | 65.6% QoQ
β€2
BPCL Q2 FY27
Net Profit: βΉ4,993 Cr vs βΉ3,962 Cr loss QoQ | β22% YoY
Revenue: βΉ1.49 lakh Cr β41% YoY | β2% QoQ
EBITDA: βΉ9,571 Cr vs βΉ2,857 Cr loss QoQ | β12% YoY
EBITDA Margin: 6.4% vs 10.2% YoY | -1.87% QoQ
Net Profit: βΉ4,993 Cr vs βΉ3,962 Cr loss QoQ | β22% YoY
Revenue: βΉ1.49 lakh Cr β41% YoY | β2% QoQ
EBITDA: βΉ9,571 Cr vs βΉ2,857 Cr loss QoQ | β12% YoY
EBITDA Margin: 6.4% vs 10.2% YoY | -1.87% QoQ
β€1
HYPERSOFT TECHNOLOGIES Q2 FY27 (CONS.)
Net Profit: βΉ8.01 Cr β233.07% YoY | β21.23% QoQ
Revenue: βΉ82.29 Cr β395.50% YoY | β6.14% QoQ
EBITDA: βΉ11.02 Cr β293.38% YoY | β2.05% QoQ
EBITDA Margin: 13.39% vs 16.87% YoY | 13.93% QoQ
Net Profit: βΉ8.01 Cr β233.07% YoY | β21.23% QoQ
Revenue: βΉ82.29 Cr β395.50% YoY | β6.14% QoQ
EBITDA: βΉ11.02 Cr β293.38% YoY | β2.05% QoQ
EBITDA Margin: 13.39% vs 16.87% YoY | 13.93% QoQ
NESCO Q2 FY27
Net Profit: βΉ105 Cr β12% YoY | β5% QoQ
Revenue: βΉ228 Cr β4% YoY | β8% QoQ
EBITDA: βΉ128 Cr β6% YoY | β25% QoQ
EBITDA Margin: 56.0% vs 56.9% YoY | 48.3% QoQ
Net Profit: βΉ105 Cr β12% YoY | β5% QoQ
Revenue: βΉ228 Cr β4% YoY | β8% QoQ
EBITDA: βΉ128 Cr β6% YoY | β25% QoQ
EBITDA Margin: 56.0% vs 56.9% YoY | 48.3% QoQ
β€2
UNICOMMERCE Q2 FY27
Net Profit: βΉ6 Cr β11% YoY | β37% QoQ
Revenue: βΉ59 Cr β15% YoY | β15% QoQ
EBITDA: βΉ9 Cr β6% YoY | β57% QoQ
EBITDA Margin: 14.5% vs 17.8% YoY | 10.6% QoQ
Net Profit: βΉ6 Cr β11% YoY | β37% QoQ
Revenue: βΉ59 Cr β15% YoY | β15% QoQ
EBITDA: βΉ9 Cr β6% YoY | β57% QoQ
EBITDA Margin: 14.5% vs 17.8% YoY | 10.6% QoQ
β€1
OFSS: Q2 REVENUE 19.1B RUPEES VS 17.9B (YOY)
OFSS: Q2 CONS NET PROFIT 7B RUPEES VS 5.5B (YOY); EST 7.4B
OFSS: Q2 EBITDA 9.26B RUPEES VS 7.55B (YOY); Q2 EBITDA MARGIN 48.55% VS 42.22% (YOY)
OFSS: Q2 CONS NET PROFIT 7B RUPEES VS 5.5B (YOY); EST 7.4B
OFSS: Q2 EBITDA 9.26B RUPEES VS 7.55B (YOY); Q2 EBITDA MARGIN 48.55% VS 42.22% (YOY)
β€4
PERSISTENT SYSTEMS: CO SEES EBIT MARGIN ASPIRATION OF 16%-17%, TARGETS NAGARRO ACQUISITION CLOSURE BY Q4 CY26
β€2
US SEN. COLLINS: APPLE, SEAWEED, BLUEBERRY, POTATO PRODUCERS TO GET CANADA TARIFF RELIEF
β€5
TRUMP ON IRAN: WE MAY DO ANOTHER OPERATION AGAINST IRAN
π16β€2π1
LEMON TREE HOTELS:
CO SIGNS A LICENSE AGREEMENT FOR A 63-ROOM KEYS LITE HOTEL IN BHILWARA, RAJASTHAN, MANAGED BY ITS UNIT CARNATION HOTELS PRIVATE LIMITED.
CO SIGNS A LICENSE AGREEMENT FOR A 63-ROOM KEYS LITE HOTEL IN BHILWARA, RAJASTHAN, MANAGED BY ITS UNIT CARNATION HOTELS PRIVATE LIMITED.
β€1π1
US President Donald Trump has hinted at another possible military operation against Iran, saying Washington may carry out βanother little Epic Furyβ.
His remarks come as the war approaches its eighth month and rising fuel prices weigh on the US midterm election climate.
His remarks come as the war approaches its eighth month and rising fuel prices weigh on the US midterm election climate.
β€2π1